Home > Healthcare > Pharmaceuticals > Pharma Manufacturing > Vaccine Contract Manufacturing Market

Vaccine Contract Manufacturing Market Share

Report ID: GMI9726
Published Date: Jun 2024
Report Format: PDF

Download Free Sample

Vaccine Contract Manufacturing Market Share

The competitive landscape of the market is characterized by the presence of several key players vying for market share. Leading pharmaceutical and biotechnology companies, contract manufacturing organizations (CMOs), and emerging players contribute to the competitive dynamics of the market.

Vaccine Contract Manufacturing Market Companies

Prominent players operating in the vaccine contract manufacturing industry include:

Ajinomoto Co., Inc.
Bavarian Nordic A/S
Catalent, Inc
Charles River Laboratories International Inc.
Curia Global, Inc.
Cytovance Biologics (Hepalink)
Emergent BioSolutions Inc.
Fujifilm Holdings Corporation
Goodwin Biotechnology Inc.
Gedeon Richter (Richter-Helm BioLogics)
ICON PLC
IDT Biologika GmbH
Lonza Group AG
Recipharm AB
Syngene International Limited

Authors: Mariam Faizullabhoy, Gauri Wani

Frequently Asked Questions (FAQ) :

Vaccine contract manufacturing market size was USD 2.7 billion in 2023 and is expected to register 11% CAGR from 2024-2032 owing to the need for cost efficiency and specialized expertise worldwide.

The attenuated segment held 30.1% share in 2023 and is expected to register a commendable CAGR from 2024-2032 due to its strong efficacy and the ability to induce both cellular and humoral immunity.

North America vaccine contract manufacturing industry reached USD 1.1 billion in 2023 and is expected to register an appreciable CAGR from 2024-2032 due to presence of well-developed pharmaceutical industry in the region.

Catalent, Inc, Fujifilm Holdings Corporation, Goodwin Biotechnology Inc., Gedeon Richter (Richter-Helm BioLogics), ICON PLC, IDT Biologika GmbH, Lonza Group AG, Recipharm AB, and Syngene International Limited, are some of the major vaccine contract manufacturing companies worldwide.